Summary
Jasper Lin is a Principal Investigator with nearly a decade of industry experience and over ten years in cancer biology, specializing in antibody-drug conjugates, multi-specific targeting molecules, and cancer immunotherapy. He has led translation-focused teams to design and execute in vitro and in vivo studies, develop multi-arm linker chemistries, and advance iPSC differentiation into hematopoietic and immune lineages. Jasper combines deep hands-on skills in large-scale mammalian protein expression and purification with strategic project leadership—defining scope, timelines, SOPs, and delivering data for PCT filings. His work spans vaccine development (protein and whole-cell) and engineering Fc- and bispecific-based modalities for T cell modulation, reflecting both biochemical rigor and therapeutic intent. Based in New Taipei, Taiwan, he pairs a PhD in Biochemistry from National Taiwan University with a pragmatic record of moving novel biologics from bench to patent stage. An underappreciated strength is his cross-cutting fluency in linker chemistry and cell-based immunology, enabling seamless integration of chemistry and biology in complex biologic constructs.
9 years of coding experience
8 years of employment as a software developer
Doctor of Philosophy (Ph.D.) Biochemistry, Doctor of Philosophy (Ph.D.) Biochemistry at National Taiwan University
English, Chinese